Skip to content

Using Diffuse Noxious Inhibitory Control (DNIC) to Predict Acupuncture Therapy Outcome: A Pilot Study

Using DNIC to Predict Acupuncture Therapy Outcome: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01088867
Enrollment
10
Registered
2010-03-17
Start date
2010-03-31
Completion date
2010-07-31
Last updated
2013-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Pain, Acupuncture, DNIC, Electroacupuncture

Brief summary

The investigators hypothesize that acupuncture modifies the DNIC efficiency and that DNIC can serve as a predictor to identify 'good responders' to acupuncture early in therapy.

Interventions

OTHERAcupuncture

Electroacupuncture

Sponsors

Bastyr University
CollaboratorOTHER
University of Washington
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy women with a progesterone-coated intrauterine device (Mirena), and * Men greater than or equal to 18 years old.

Exclusion criteria

* Acupuncture treatment in the previous six weeks, to discount any persisting effect of acupuncture. * Treatment of a pain condition with pain medication. * Regular use of benzodiazepines. * Skin diseases, such as scleroderma, psoriasis or eczema. * An adverse event due to acupuncture therapy. * Pregnant women. * Women without a progesterone-coated intrauterine device (Mirena). * Anyone older than 60 years of age, fatigued, with a pacemaker ICD, artificial joint, prolonged bleeding time/hemophilia, open wounds, or a known susceptibility to profound analgesia after acupuncture treatment.

Design outcomes

Primary

MeasureTime frameDescription
Diffuse Noxious Inhibitory Control EfficiencyWeek 0, 2, 4, 6, and 12 of acupuncture therapyThe efficiency of diffuse noxious inhibitory control (DNIC) is a measure of one's ability to inhibit pain perception. DNIC efficiency is assessed by a psychophysical test that involves a heat thermode as the test stimulus and a warm water bath as the conditioning stimulus. The results of this test will be used as the primary outcome measure.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026